STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT01702636
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 100 participants
- Registry
-
NCT01702636
-
- Other papers using this trial's data
- Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Australia, Finland
- Registry status
- Completed
Technical summary
Registry record NCT01702636. Randomized; quadruple masking; primary purpose treatment. Start 2012-12 (actual); primary completion 2019-08-14 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial
- Acronym
- STOP-AUST
- Condition
- Intracerebral Haemorrhage
- Condition
- Stroke
- Intervention (Drug)
- Tranexamic Acid
- Intervention (Drug)
- Placebo
- Lead sponsor
- Neuroscience Trials Australia
Record details
- Record id
cardio:ct-nct01702636- Content hash
8c5e63dc38df0fbeb3e5abeb452281c0f7cbb8b01ec1c1d72882dbdf3aff8b0d